Shares of Clean Energy Fuels plunged 10.9% to $1.66 after the company's second-quarter results revealed a decelerating growth engine at a time when it can least afford one. Revenue came in at $106.4 million, up from $102.6 million a year ago — a 3.7% gain that, while slightly above the $105.1 million consensus estimate , fell short of other analyst forecasts calling for $111.3 million . The mixed signals spooked a market already on edge.

  • RNG Volume Growth Stalled at a Critical Moment. RNG gallons sold reached 63.2 million in Q2, a mere 2.9% increase over the prior year . Wall Street had expected revenue growth of roughly 2.4%, but that already reflected a slowdown from the 4.8% pace of Q2 2025 . For a company whose entire thesis rests on fleet adoption of renewable natural gas, sub-3% volume growth suggests the transition to cleaner truck fuel is hitting a plateau — or at least a pause — precisely when scale is needed to reach profitability.

  • Losses Narrowed, but Cash Is Draining. The GAAP net loss shrank to $14.9 million ($0.07/share) from $20.2 million ($0.09/share) a year earlier — progress, but not enough. Adjusted EBITDA (a rough proxy for operating cash generation) fell to $16.0 million from $17.5 million, while cash and investments dipped to $138 million from $156.1 million at year-end 2025 . At that burn rate, the balance sheet runway is finite. Analysts do not forecast profitability for at least three years .

  • Management's Optimism Clashes with Street Skepticism. CEO Clay Corbus called the quarter "continued solid execution," citing growing fleet demand for lower-carbon fuel . Yet the company maintained — rather than raised — full-year guidance, offering no catalyst to reverse sentiment. UBS had already downgraded CLNE to Neutral in July, citing slow RNG project progress and disappointing returns across the sector . Falling D3 RIN credit prices and a market shift toward renewable diesel have further constrained near-term upside .

  • The Valuation Question Gets Harder to Answer. At $1.66, CLNE now trades near its 52-week low , with a market cap around $370 million against roughly $425 million in trailing annual revenue — yet the company still loses money. A director sold 165,000 shares in May , adding to the cautious optics. Until volume growth re-accelerates or a clear path to breakeven emerges, patient shareholders are being asked to fund a transition story that is running out of momentum.